10x Genomics (TXG) Research & Development (2018 - 2025)
Historic Research & Development for 10x Genomics (TXG) over the last 8 years, with Q4 2025 value amounting to $56.0 million.
- 10x Genomics' Research & Development fell 1642.43% to $56.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $238.6 million, marking a year-over-year decrease of 984.74%. This contributed to the annual value of $238.6 million for FY2025, which is 984.74% down from last year.
- According to the latest figures from Q4 2025, 10x Genomics' Research & Development is $56.0 million, which was down 1642.43% from $57.2 million recorded in Q3 2025.
- 10x Genomics' 5-year Research & Development high stood at $71.5 million for Q2 2023, and its period low was $41.9 million during Q1 2021.
- In the last 5 years, 10x Genomics' Research & Development had a median value of $64.2 million in 2022 and averaged $62.6 million.
- Its Research & Development has fluctuated over the past 5 years, first surged by 9394.23% in 2021, then tumbled by 1642.43% in 2025.
- Over the past 5 years, 10x Genomics' Research & Development (Quarter) stood at $61.9 million in 2021, then rose by 2.79% to $63.6 million in 2022, then grew by 2.6% to $65.3 million in 2023, then increased by 2.61% to $67.0 million in 2024, then dropped by 16.42% to $56.0 million in 2025.
- Its Research & Development stands at $56.0 million for Q4 2025, versus $57.2 million for Q3 2025 and $61.2 million for Q2 2025.